The HCP5 single-nucleotide polymorphism: A simple screening tool for prediction of hypersensitivity reaction to abacavir

Journal of Infectious Diseases

Volumn 198, Issue 6, 2008, Pages 864-867

  Colombo, Sara ^a   Rauch, Andri ^b,g   Rotger, Margalida ^a   Fellay, Jacques ^d   Martinez, Raquel ^a   Fux, Christoph ^b   Thurnheer, Christine ^b   Günthard, Huldrych F ^b,c   Goldstein, David B ^d   Furrer, Hansjakob ^b   Telenti, Amalio ^a   Battegay, M ^a   Bernasconi, E ^a   Boni J ^a   Bucher, H C ^a   Burgisser Ph ^a   Calmy, A ^a   Cattacin, S ^a   Cavassini, M ^a   Dubs, R ^a   Egger, M ^a   Elzi, L ^a   Erb, P ^a   Fischer, M ^a   Flepp, M ^a   Fontana, A ^a   Francioli, P ^a   Furrer, H ^e   Fux, C ^f   Gorgievski, M ^f   Gunthard H ^f   Hirsch, H ^g   Hirschel, B ^g   Hosli I ^g   Kahlert, Ch ^g   Kaiser, L ^g   Karrer, U ^g   Kind, C ^g   Klimkait, Th ^g   Ledergerber, B ^g   Martinetti, G ^g   Martinez, B ^g   Muller N ^g   Nadal, D ^g   Opravil, M ^g   Paccaud, F ^g   Pantaleo, G ^g   Regenass, S ^g   Rickenbach, M ^g   Rudin, C ^h   Schmid, P ⁱ   Schultze, D ⁱ   Schupbach J ⁱ   Speck, R ⁱ   Taffe P ⁱ   Tarr, P ⁱ   Telenti, A ⁱ   Trkola, A ⁱ   Vernazza, P ⁱ   Weber, R ⁱ   Yerly, S ⁱ   more..

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d DUKE UNIVERSITY   (United States)

^e Clinical and Laboratory Committee

^f Scientific Board

^g Data Center

^h Mother and Child Substudy

ⁱ Mother and Child Substudy ^*

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR;

ARTICLE; DRUG TOLERANCE; GENE LINKAGE DISEQUILIBRIUM; GENETIC SCREENING; GENOTYPE; HCP5 SINGLE NUCLEOTIDE POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYPERSENSITIVITY REACTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

EID: 51749105925     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/591184     Document Type: Article

References (13)

1. Cutrell AG, Hernandez JE, Fleming JW, et al. Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir. Ann Pharmacother 2004; 38:2171-2.
2. Mallal S, Nolan D, Witt C, et al. Association between presence of HLAB* 5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002; 359:727-32.
3. Hetherington S, Hughes AR, Mosteller M, et al. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 2002; 359:1121-2.
4. Rauch A, Nolan D, Martin A, McKinnon E, Almeida C, Mallal S. Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study. Clin Infect Dis 2006; 43:99-102.
5. Mallal S, Phillips E, Carosi G, et al. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med 2008; 358:568-79.
6. Martin AM, Nolan D, Mallal S. HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing. Tissue Antigens 2005; 65:571-4.
7. Martin AM, Krueger R, Almeida CA, Nolan D, Phillips E, Mallal S. A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome. Pharmacogenet Genomics 2006; 16:353-7.
8. Chui CK, Brumme ZL, Brumme CJ, et al. A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase. Clin Infect Dis 2007; 44:1503-8.
9. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006; 38:1166-72.
10. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007; 317:944-7.
11. Witt CS, Price P, Kaur G, et al. Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe. Tissue Antigens 2002; 60:474-80.
12. Nolan D, Thorborn D, Schaefer M, et al. Genetic factors predicting ABC-HSR and ABC tolerance in HLA-B*5701-positive individuals: combined analysis from PREDICT-1, SHAPE, and a multinational study [abstract 982]. In: Program and abstracts of the 15th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts, 3-6 February 2008. Alexandria, VA: Conference on Retroviruses and Opportunistic Infections. Available at: http://www.retroconference.org/2008/PDFs/982.pdf. Accessed 9 July 2008.
13. Hammond E, Almeida CA, Mamotte C, et al. External quality assessment of HLA-B*5701 reporting: an international multicentre survey. Antivir Ther 2007; 12:1027-32.